NCT06470308

Brief Summary

Polypharmacy is a common and growing public health concern across healthcare settings worldwide and is associated with an increased risk of inappropriate prescribing and adverse drug events. Deprescribing-defined as the supervised withdrawal of potentially inappropriate medications using structured tools and clinical judgment-has been proposed as a strategy to improve prescribing safety. In Greece, formal initiatives and evidence evaluating deprescribing interventions in primary care remain limited. This study is a cluster randomized controlled trial evaluating the effect of an educational intervention for general practitioners (GPs) on prescribing safety in primary care. Participating GPs are randomized in an approximately 1:1 ratio to an intervention or control arm. GPs in the intervention arm receive structured education and training on medication review and deprescribing, including the use of validated deprescribing tools such as the Beers Criteria. GPs in the control arm provide usual care and do not receive any educational intervention. Patients receiving care from participating GPs are recruited, and prescribing outcomes are assessed at the patient level. The primary outcome is change in prescription medications following the intervention, comparing patients cared for by GPs in the intervention arm versus those cared for by GPs in the control arm.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 17, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 24, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

November 18, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

February 9, 2026

Status Verified

February 1, 2026

Enrollment Period

1.1 years

First QC Date

June 17, 2024

Last Update Submit

February 4, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Potentially Inappropriate Medication

    Determine if there is reduction in potentially Inappropriate medication after a deprescribing education intervention

    1 years

  • Number of medications

    Determine if there is reduction in number of medications after a deprescribing education intervention

    1 year

Study Arms (2)

Intervention Arm

EXPERIMENTAL

An educational intervention and training in deprescribing algorithms and deprescribing tools ( Beers Criteria) will be provided to the general practitioners caring for the patients selected in the intervention arm.

Other: Medication Reviews and Deprescribing

Control Arm

NO INTERVENTION

No educational intervention will be provided to the general practitioners of the selected patients.

Interventions

General Practitioners will be given training and education in deprescribing algorithms and the conduction of medication reviews with the use of validated deprescribing tools such as the Beers Criteria.

Intervention Arm

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • community-dwelling patients
  • Age ≥ 65 years
  • Receive at least 5 medication ( polypharmacy )

You may not qualify if:

  • hospitalized or patients living in nursing home
  • Incapable of giving written consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Primary Care Facilities

Heraklion, Heraklion, Crete, 71303, Greece

Location

MeSH Terms

Conditions

Prescription Drug OveruseFrailty

Interventions

Medication ReviewDeprescriptions

Condition Hierarchy (Ancestors)

Prescription Drug MisuseDrug MisuseSubstance-Related DisordersChemically-Induced DisordersMental DisordersPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Medication SystemsOrganization and AdministrationHealth Services AdministrationPatient Care ManagementDrug TherapyTherapeutics

Study Officials

  • Ioanna Tsiligianni, MD, PhD

    Associate Professor in General Practice and Public Health, Department of Social Medicine, University of Crete

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD , PhD Candidate

Study Record Dates

First Submitted

June 17, 2024

First Posted

June 24, 2024

Study Start

November 18, 2024

Primary Completion

December 30, 2025

Study Completion

March 1, 2026

Last Updated

February 9, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

All the data that will be collected, will be retained only during the period needed for the aims of this research. Technical and organizational measures will be taken in order to minimize potential loss, destruction or corruption of the data.After the completion of the thesis , all the data will be destroyed.

Locations